These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
585 related articles for article (PubMed ID: 17311868)
1. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF. Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868 [TBL] [Abstract][Full Text] [Related]
2. Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma. Yang LY; Lu WQ; Huang GW; Wang W BMC Cancer; 2006 May; 6():110. PubMed ID: 16650286 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic implications of endoglin (CD105) expression in hepatocellular carcinoma and its adjacent non-tumorous liver. Ho JW; Poon RT; Sun CK; Xue WC; Fan ST World J Gastroenterol; 2005 Jan; 11(2):176-81. PubMed ID: 15633211 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas. Netto GC; Bleil CB; Hilbig A; Coutinho LM Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830 [TBL] [Abstract][Full Text] [Related]
5. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma]. Li Q; Zhang B; Peng P Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257 [TBL] [Abstract][Full Text] [Related]
6. Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Barresi V; Cerasoli S; Vitarelli E; Tuccari G Acta Neuropathol; 2007 Aug; 114(2):147-56. PubMed ID: 17594108 [TBL] [Abstract][Full Text] [Related]
7. CD105 expression is an independent predictor of survival in patients with endometrial cancer. Erdem O; Taskiran C; Onan MA; Erdem M; Guner H; Ataoglu O Gynecol Oncol; 2006 Dec; 103(3):1007-11. PubMed ID: 16854456 [TBL] [Abstract][Full Text] [Related]
8. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy. Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287 [TBL] [Abstract][Full Text] [Related]
9. CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34. Miyata Y; Sagara Y; Watanabe S; Asai A; Matsuo T; Ohba K; Hayashi T; Sakai H Virchows Arch; 2013 Nov; 463(5):673-9. PubMed ID: 23975255 [TBL] [Abstract][Full Text] [Related]
10. Correlation between selected angiogenic markers and prognosis in pediatric adrenocortical tumors: Angiogenic markers and prognosis in pediatric ACTs. Dias AI; Fachin CG; Avó LR; Frazão CV; Caran EM; Schettini ST; Alves MT; Ribeiro RC; Abib Sde C J Pediatr Surg; 2015 Aug; 50(8):1323-8. PubMed ID: 25783314 [TBL] [Abstract][Full Text] [Related]
11. Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma. Yu D; Zhuang L; Sun X; Chen J; Yao Y; Meng K; Ding Y BMC Cancer; 2007 Jul; 7():122. PubMed ID: 17608955 [TBL] [Abstract][Full Text] [Related]
12. Microvessel density assessment in benign and malignant endometrial changes. Czekierdowski A; Czekierdowska S; Czuba B; Cnota W; Sodowski K; Kotarski J; Zwirska-Korczala K J Physiol Pharmacol; 2008 Sep; 59 Suppl 4():45-51. PubMed ID: 18955753 [TBL] [Abstract][Full Text] [Related]
13. Morphometric and immunohistochemical study of angiogenic marker expressions in invasive ductal carcinoma of human breast. Safwat MD; Habib F; Elayat A; Oweiss N; Reffat S; Algaidi S Folia Morphol (Warsz); 2009 Aug; 68(3):144-55. PubMed ID: 19722158 [TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Ding S; Li C; Lin S; Yang Y; Liu D; Han Y; Zhang Y; Li L; Zhou L; Kumar S Hum Pathol; 2006 Jul; 37(7):861-6. PubMed ID: 16784986 [TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of vasohibin 1-associated angiogenesis in patients with hepatocellular carcinoma. Murakami K; Kasajima A; Kawagishi N; Sekiguchi S; Fujishima F; Watanabe M; Sato Y; Ohuchi N; Sasano H Hum Pathol; 2014 Mar; 45(3):589-97. PubMed ID: 24444468 [TBL] [Abstract][Full Text] [Related]
16. [Tumor microvascular density detected by anti-CD105 and anti-CD34 in hepatocellular carcinoma patients and its predictive value of tumor recurrence after liver transplantation]. Wang Y; Zhang XH; Guo P; Yan LN; He D Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):818-21. PubMed ID: 21302449 [TBL] [Abstract][Full Text] [Related]
17. Microvascular density of regenerative nodule to small hepatocellular carcinoma by automated analysis using CD105 and CD34 immunoexpression. Paschoal JP; Bernardo V; Canedo NH; Ribeiro OD; Caroli-Bottino A; Pannain VL BMC Cancer; 2014 Feb; 14():72. PubMed ID: 24507660 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. El-Assal ON; Yamanoi A; Soda Y; Yamaguchi M; Igarashi M; Yamamoto A; Nabika T; Nagasue N Hepatology; 1998 Jun; 27(6):1554-62. PubMed ID: 9620326 [TBL] [Abstract][Full Text] [Related]
20. [Expressions of inducible nitric oxide synthase and vascular endothelial growth factor and their relationship with microvessel density in hepatocellular carcinoma]. Xiao G; Zhang WM; Zhang M; Xie D; Guo AL; Wen JM Ai Zheng; 2005 Jan; 24(1):99-103. PubMed ID: 15642211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]